Genomic characterization of plasmid-borne colistin resistance variants, mcr-1.1 and mcr-1.26, in multidrug-resistant Escherichia coli isolated from backyard farm animals
Colistin remains a high-priority, critically important antimicrobial that is used for treating severe infections caused by multidrug-resistant (MDR) Gram-negative bacteria. However, colistin resistance and the emergence of the mobile colistin resistance (mcr) genes have been increasingly documented...
Saved in:
| Main Author: | Dina, Daaboul (author) |
|---|---|
| Other Authors: | Kassem, Issmat I. (author), El Omari, Khaled (author), Eltai, Nahla O. (author), Hassan, Jouman (author), Al Jamal, Hadi (author), Fayad, Souad (author), Salma, Rayane (author), Ghorbani Tajani, Anahita (author), Bisha, Bledar (author), Hamze, Monzer (author), Oueslati, Saoussen (author), Cummings, Kevin J. (author), Dabboussi, Fouad (author), Naas, Thierry (author), Osman, Marwan (author) |
| Format: | article |
| Published: |
2024
|
| Subjects: | |
| Online Access: | http://dx.doi.org/10.1016/j.jgar.2024.06.009 https://www.sciencedirect.com/science/article/pii/S2213716524001206 http://hdl.handle.net/10576/57489 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Plasmid-mediated colistin resistance encoded by mcr-1 gene in Escherichia coli co-carrying blaCTX-M-15 and blaNDM-1 genes in pediatric patients in Qatar
by: Tsui, Clement K. M.
Published: (2020) -
Seroprevalence of influenza A H1N1 and influenza D viruses in ruminants in Qatar
by: Hadeel T., Zedan
Published: (2025) -
Adipocyte Enhancer-Binding Protein 1 (AEBP1) (a Novel Macrophage Proinflammatory Mediator) Overexpression Promotes and Ablation Attenuates Atherosclerosis in ApoE⁻′⁻ and LDLR⁻′⁻ Mice
by: Bogachev, Oleg
Published: (2011) -
Efficacy and Safety of Colistin versus Tigecycline for Multi-Drug-Resistant and Extensively Drug-Resistant Gram-Negative Pathogens—A Meta-Analysis
by: Dina Abushanab (10696501)
Published: (2022) -
Serum immune mediators as novel predictors of response to anti-PD-1/PD-L1 therapy in non-small cell lung cancer patients with high tissue-PD-L1 expression
by: Afsheen Raza (492657)
Published: (2023)